Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study

Table 2 Serum concentrations of LBP and sCD14 as related to metabolic syndrome and its separate constituents

	LBP (µg/mL)	p	sCD14 (ng/mL)	p
MetS
+	13.1 (11.2, 15.5)	0.11	1285 (1057, 1483)	0.71
–	12.7 (10.3, 14.9)	0.11	1306 (1053, 1538)	0.71
Waist circumference
> 102 cm	13.2 (11.2, 15.7)	0.04	1299 (1078, 1494)	0.41
≤ 102 cm	12.6 (10.2, 14.9)	0.04	1294 (1033, 1535)	0.41
Blood pressure
> 130/85 mmHg	12.9 (10.5, 15.2)	0.87	1294 (1051, 1499)	0.36
≤ 130/85 mmHg	13.0 (10.9, 15.0)	0.87	1309 (1053, 1627)	0.36
Fasting glucose
≥ 5.6 mmol/L	12.9 (10.5, 15.3)	0.99	1299 (1065, 1494)	0.95
< 5.6 mmol/L	12.9 (10.6, 15.0)	0.99	1293 (1004, 1566)	0.95
HDL-cholesterol
< 1.04 mmol/L	13.8 (11.1, 15.9)	0.15	1309 (1039, 1594)	0.72
≥ 1.04 mmol/L	12.8 (10.5, 15.1)	0.15	1295 (1052, 1518)	0.72
Triglycerides
> 1.7 mmol/L	13.0 (10.8, 15.4)	0.69	1284 (1061, 1495)	0.87
≤ 1.7 mmol/L	12.7 (10.4, 15.0)	0.69	1297 (1030, 1530)	0.87
Fasting glucose
≤ 5.5	12.9 (10.6, 15.0)	0.99*	1289 (1008, 1558)	0.71*
5.6–6.9	12.8 (10.6, 15.1)		1297 (1072, 1467)
≥ 7.0	13.1 (10.5, 15.3)		1317 (1056, 1589)

Median values are given (25, 75 percentiles). P-values refers to differences between groups. * Kruskall–Wallis test. Italic text indicates p-values below < 0.05

ISSN: 1758-5996